Asymchem Biologics

Asymchem Biologics

凯莱英生物

Asymchem Biologics

Biotech/Healthcare

AsymBio is a subsidiary of Asymchem Pharmaceutical Group focused on CDMO services. It provides dedicated contract development and manufacturing services for large-molecule biologics, antibody-drug conjugates, cell and gene therapies, mRNA therapeutics, and other products.

Latest round: Strategic (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-03-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.